Treatment of left ventricular thrombi with a low molecular weight heparin

International Journal of Cardiology

Volumn 98, Issue 2, 2005, Pages 319-323

  Meurin, Philippe ^a   Tabet, Jean Yves ^b   Renaud, Nathalie ^a   Weber, Hélène ^a   Grosdemouge, Anne ^a   Bourmayan, Claude ^a   Driss, Ahmed Ben ^a  

^a Ctr Readaptation Cardiaque la Brie   (France)

^b BEAUJON HOSPITAL   (France)

Author keywords

Left ventricular thrombus; Low molecular weight heparin

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; CLOPIDOGREL; ENOXAPARIN; FLUINDIONE; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART VENTRICLE THROMBOSIS; HUMAN; MALE; MULTICENTER STUDY; OPEN STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTOPENIA; TRANSIENT ISCHEMIC ATTACK; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

EID: 15944385280     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.02.014     Document Type: Article

References (23)

1. Van Dantzig J.M., Delamarre J., Bot H., Visser C. Left ventricular thrombus in acute myocardial infarction. Eur. Heart J. 17:1996;1640-1645
2. Domenicucci S., Francesco C., Bellotti P., et al. Long term prospective assesment of left ventricular thrombus in anterior wall acute myocardical infarction and implications for a national approach to embolic risk. Am. J. Cardiol. 83:1999;519-524
3. Vaitkus P., Barnathan E. Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis. J. Am. Coll. Cardiol. 22:1993;1004-1009
4. Motro M., Barbash G.I., Hod H., et al. Incidence of left ventricular thrombus formation after thrombolytic therapy with recombinant tissue plasminogen activator, heparin and aspirin in patients with acute myocardial infarction. Am. Heart J. 122:1991;23-26
5. Kalra A., Jang I.K. Prevalence of early left ventricular thrombus after primary coronary intervention for acute myocardial infarction. J. Thromb. Thrombolysis. 10(2):2000;133-136
6. Greave S.C., Zhi G., Lee R.T., et al. Incidence and natural history of left ventricular thrombus following anterior wall acute myocardial infarction. Am. J. Cardiol. 80(4):1997;442-448
7. Ciaccheri M., Castelli G., Cecci F., et al. Lack of correlation between intra-cavitary thrombosis detected by cross sectional echocardiography and systemic emboli in patients with dilated cardiomyopathy. Br. Heart J. 62:1989;23-26
8. Gottdiener J.S., Gay J.A., Vanvoorheeg L., Di Bianco R., Fletcher R. Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by two dimensional echocardiography. Am. J. Cardiol. 52:1983;1281-1285
9. Bellotti P., Claudiani F., Chiarella F., et al. Left ventricular thrombus changes in size and in platelet deposition during treatment with indobufen and ticlopidine. Cardiology. 77(4):1990;272-279
10. Kontny F., Dale J., Abildgaard U., Pedersen T.R. Randomized trial of low molecular weight heparin (dalteparin) in prevention of left ventricular thrombi formation and arterial embolism after acute anterior myocardial infarction: the Fragmin Acute Myocardial Infarction (FRAMI) study. J. Am. Coll. Cardiol. 30(4):1997;962-969
11. Iacono A. Mean term calcium heparin treatment in acute transmural anterior myocardial infarction: effects on left ventricular thrombosis and its complications. Cardiologia. 42(12):1997;1251-1255
12. Stratton J.R., Resmik A.D. Increased embolic risk in patients with left ventricular thrombi. Circulation. 75(5):1987;1004-1011
13. Cregler I.I., Ga A. Anti-thrombotic therapy in left ventricular thrombosis and systemic embolism. Am. Heart J. 123:1992;1110-1114
14. Nili M., Deviri E., Jortner R., Strasberg B., Levy M.J. Surgical removal of a mobile, pedunculated left ventricular thrombus: report of 4 cases. Ann. Thorac. Surg. 46:1988;396-400
15. Carpenter K., Adams D. Apical mural thrombus: technical pitfalls. Heart. 80(suppl. 1):1988;56-58
16. Weitz J.L. Low molecular weight heparins. N. Engl. J. Med. 337:1997;447-452
17. Cohen M., Demers C., Gurfinkel E., et al. Comparison between low molecular weight heparin with unfractionated heparin for unstable coronary artery disease. N. Engl. J. Med. 337:1997;447-452
18. Montalescot G., Polle V., Collet J.P., et al. Low molecular weight heparin after mechanical heart valve replacement. Circulation. 101:2000;1083-1086
19. Bechtold H., Gunzenhauser D., Sawitzki H., Fung S., Janssen D. Anticoagulation with the low molecular weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion. Z. Kardiol. 92(7):2003;532-539
20. Heik S., Kupper W., Hamm C., Bleifeld W., Koschyk D., Waters D., et al. Efficacy of high dose intravenous heparin for treatment of left ventricular thrombi with high embolic risk. J. Am. Coll. Cardiol. 24:1994;1305-1309
21. Mallory R., Balcezak T. Treatment of a mobile left ventricular thrombus with low molecular weight heparin. Letter to the editor. N. Engl. J. Med. 341(14):1999;1082-1083
22. Stratton J.R., Resnick A.D. Increased embolic risk in patients with LV ventricular thrombi. Circulation. 75:1987;1004-1011
23. Mollet N.R., Dymarkowski S., Volders W., et al. Visualization of ventricular thrombi with contrast enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation. 106(23):2002;2873-2876